본문 바로가기

Chodang R&D

Global new drug R&D with the best technology

HOME > R&D > Development

Development

R&D PipelineThe Chodang Institute conducts research and clinical trials on various diseases.

  • Title
  • Indicants
  • Developmental stages
  • CD 250
  • Hematological malignancies
  • Discovery
  • CD 430
  • Antithrombotic
  • Preclinical
  • CD 650
  • Colorectal cancer
  • Discovery
  • CD 010
  • Antiplatelet agent
  • Grant application accepted
  • CP 010
  • CNS medicine
  • Preclinical
  • CD 020
  • Urinogenital organ medicine
  • Preclinical
  • CD 030
  • Osteoporosis
  • Preclinical

WORLD SHIPPING

PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :

GO
닫기